DIANE DABRINGHAUS: Open Payments
NPI 1710350475 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 17 payments from 9 companies in 2025. Trend: 2023 $560 · 2024 $626 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $97 |
| Hologic Sales and Service, LLC | 2 | $77 |
| Biogen, Inc. | 3 | $76 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| PFIZER INC. | 1 | $25 |
| Organon LLC | 1 | $21 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $18 |
Products named: Veozah, ZURZUVAE, THINPREP 2000 PROCESSOR, MYFEMBREE, JOURNAVX, APTIMA, ABRYSVO, Lynkuet.
Industry payments across FL — which companies pay providers there.
